Evidence 360 Summit
RWE, Market Access & Pricing
Bringing together senior leaders across real-world evidence, market access, health economics and outcomes research (HEOR), payers, and pricing & reimbursement to explore the next generation of evidence-driven healthcare decision-making.
Event Overview
The 3rd Annual Evidence 360 Summit — RWE, Market Access & Pricing, hosted by Veridon Global, will take place on 11–12 March 2027 in Basel, Switzerland. It will bring together leading decision-makers representing pharma, biotech, RWE, HEOR, HTAs, payers, pricing & reimbursement groups, academia, and technology.
This year's edition focuses on integrating an innovative approach to evidence generation and the access journey. Instead of treating RWE, HEOR, Market Access, and Pricing as isolated activities, we explore how they align across early development, launch, reimbursement, and post-launch evidence.
Key discussions will examine evolving European evidence requirements driven by changing HTA practices, demand for comparative real-world evidence, payer expectations, and value demonstration beyond clinical endpoints.
The summit emphasizes the practical connection between evidence generation and market access outcomes—helping teams design, evaluate, and leverage evidence to influence pricing, reimbursement, and patient access.
Send an Enquiry
Have questions? Fill in your details below.
Connecting Evidence Generation to Real Market Access Outcomes
The agenda will feature practical pharma case studies, payer and HTA perspectives, interactive panel discussions, and expert-led sessions bringing together stakeholders across the entire evidence-to-access journey.
Evidence 360 Summit at a Glance
Key Areas of Focus
The programme for 2027 includes important trends in:
Why Basel?
Basel provides an ideal venue for a real-world evidence and market access meeting in Europe as it is home to an abundance of pharmaceutical, biotech, HEOR, market access and life sciences organisations. It allows us to have access to a unique European pharma and payer community bridging the Swiss, German and French life science ecosystems. Basel allows us to create a more diverse regional audience while keeping the senior-focused, tightly-packed nature of the Evidence 360 Summit intact.
Who Should Attend
The summit is targeted at senior professionals working in: Pharmaceutical & Biotechnology areas like-
Why Attend
Exclusive Insights
Latest advances in real-world evidence, market access, and pricing strategy.
Collaboration
Connect with pharma, payer, and HEOR leaders.
Access Strategies
Explore value-based pricing, innovative contracting, and reimbursement models.
RWE Integration
Real-world data generation, outcomes research, and evidence-based decision-making.
Regulatory Trends
Updates on global frameworks for market access and HTA processes.
2027 Edition Speakers
From Market Access Leaders to Real-World Evidence Pioneers
Join an exceptional lineup of leading experts and industry innovators advancing the future of evidence-based healthcare decision-making. The 2027 edition will bring together influential voices from pharmaceutical and biotech companies, payer organizations, HTA bodies, and academic research centers—covering the full spectrum of real-world evidence, market access, pricing, and HEOR.
Agenda
REAL-WORLD EVIDENCE: GENERATION, STRATEGY & DATA-DRIVEN DECISION-MAKING
| Time | Session |
|---|---|
| 8:00 — Registration and Refreshments | |
| 8:50 | Welcome Note by Veridon Global |
| 8:55 | Opening Address by the Chairperson |
| SESSION 1: REAL-WORLD EVIDENCE GENERATION & STRATEGY | |
| 9:00 | Building a Fit-for-Purpose RWE Strategy Across the Product Lifecycle |
| 9:25 | Real-World Data Sources: Quality, Access & Interoperability |
| 9:50 | Leveraging RWE to Support Regulatory & HTA Submissions |
| 10:15 | Morning Refreshments, Poster Presentations & One-to-One Networking Meetings |
| 10:45 | Patient-Reported Outcomes & Real-World Effectiveness Studies |
| 11:10 | AI & Advanced Analytics in Evidence Generation |
| 11:35 | Panel Discussion: The Future of Real-World Evidence — What Will Define the Next Decade? |
MARKET ACCESS & PRICING: VALUE, PAYER STRATEGY & GLOBAL ACCESS
| Time | Session |
|---|---|
| 8:30 — Registration & Morning Coffee | |
| 8:55 | Opening Remarks by the Chairperson |
| SESSION 2: MARKET ACCESS, PRICING & PAYER STRATEGY | |
| 9:00 | Global Pricing & Reimbursement: Navigating Cross-Country Access |
| 9:25 | Value-Based Pricing & Innovative Contracting Models |
| 9:50 | Payer & HTA Perspectives: What Evidence Really Moves Decisions |
| 10:15 | Networking Break & One-to-One Partnering Meetings |
| 10:45 | Market Access Readiness for Emerging Therapies |
Download the full agenda to view all sessions, panel discussions, and networking slots.
Our Esteemed Sponsors & Exhibitors
Supported by global pharmaceutical leaders, payer organizations, HEOR consultancies, and market access innovators shaping the future of evidence-based healthcare decision-making.
Media Partners
Collaborating with global life sciences publications, market access networks, and healthcare media outlets.
Past Sponsors
Trusted by industry pioneers and global pharmaceutical, payer, and market access leaders from previous editions.
Why Sponsor?
Maximize your brand influence, present groundbreaking research, and form valuable commercial partnerships with top-tier decision-makers.
Dedicated Prime Speaking Slot
Exhibition Opportunity
One-to-One Meetings
Pre-Qualified Leads
High-Level Networking
Brand Impact
Glimpses Of Our Past Edition
Highlights from high-level keynotes, interactive panel debates, and strategic networking sessions.
Venue
Basel bridges Switzerland, Germany, and France, and is home to Europe's densest pharmaceutical, payer, and market access ecosystem. Venue details will be announced soon.
Basel, Switzerland
Venue to be announced
Contact Our Team Today
Where collaborations spark and the future of real-world evidence and market access innovation begins.
For Speaking & Partnerships
Nikita Patankar Parab
Founder, Managing Director
nikita@veridonglobal.com